抗瘤免疫依赖于通过单细胞驱动的反应准组织稳态,而不是直接瘤细胞毒性
Nicholas Koelsch1, Faridoddin Mirshahi2,3, Hussein F Aqbi4
1Department of Microbiology & Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
bioRxiv : the preprint server for biology
|June 21, 2024
概括
饮食纠正逆转了与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 到肝癌 (HCC) 的进展. 恢复肝脏组织完整性,而不仅仅是免疫激活,为癌症预防创造了一个瘤敌对的环境.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 代谢功能障碍相关的脂肪肝疾病 (MAFLD) 是肝细胞癌 (HCC) 的前体.
- 导致MAFLD进展为HCC的免疫机制尚未完全理解.
研究的目的:
- 在MAFLD向HCC的进展过程中调查免疫微环境.
- 确定饮食干预对MAFLD驱动的HCC和相关免疫反应的影响.
主要方法:
- 使用了一种慢性西方饮食 (WD) 鼠标模型.
- 采用单核RNA测序来追踪MAFLD的进展和对饮食纠正的反应.
- 分析了免疫细胞种群及其与肝细胞的相互作用.
主要成果:
- 在MAFLD期间,癌症发生开始,在HCC缓解后观察到休眠瘤细胞.
- 肝脏表现出积极的免疫反应,向恒温的树突细胞和肝细胞,而不是主要是瘤细胞.
- 自然杀手T (NKT) 细胞在WD中占主导地位,单细胞在HCC进展过程中增加;饮食纠正增强了单细胞驱动的保护性免疫力.
- 肝脏组织的完整性和恒常通路,而不是仅仅是免疫激活,决定瘤的命运.
- 与健康对照群不同,与HCC保护相关的独特免疫模式需要免疫重编程.
结论:
- 免疫通路具有双重作用,根据目标细胞塑造不同的结果.
- 恢复组织平衡和再生对于创建瘤敌对的微环境至关重要.
- 组织重塑策略对于癌症的预防和治疗至关重要,优于瘤导向的方法.
相关概念视频
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cell-mediated Immune Responses
68.1K
Overview
68.1K
Cytotoxic T Cells-mediated Immune Response
889
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
889
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
T Cell Activation and Clonal Selection
701
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
701


